CUE Market Cap History



Below is a table of the CUE market cap history going back to 1/2/2018:

Date CUE Market Cap
1/2/2018226.28M
3/22/2018331.55M
5/9/2018242.17M
8/8/2018169.32M
11/8/2018147.38M
3/7/2019131.66M
5/1/2019167.10M
8/1/2019184.95M
11/1/2019198.44M
3/6/2020545.34M
5/1/2020667.43M
8/3/2020587.27M
11/2/2020343.05M
3/1/2021406.60M
5/3/2021384.18M
8/2/2021335.56M
11/1/2021416.39M
3/7/2022164.06M
5/2/2022145.03M
8/1/202293.76M
11/1/2022102.62M
3/13/2023115.69M
5/1/2023193.44M
8/1/2023169.95M
11/1/202391.15M

Also see: CUE Shares Outstanding History
and CUE YTD Return
CUE Historical Market Cap:
-14.44% CAGR
CUE Historical Market Cap: +-14.44% CAGR

Mouse over chart for data details
1/2/2018 ...11/1/2023
Cue Biopharma is a clinical-stage biopharmaceutical company. Co.'s proprietary Immuno-Selective Targeting and Alteration of T Cells (Immuno-STAT™) platform, enable Co. to restore health while avoiding the side effects of immune activation in the case of cancer and immune suppression in the case of autoimmune disease. Co. focused its internal resources on drug product candidates in its CUE-100 series of Immuno-STATs. The CUE-100 series uses the selectivity of the T cell receptor combined with rationally engineered interleukin 2 in context of the core Immuno-STAT framework for selective activation of targeted tumor-specific T cells to potentially address a range of cancers. We show 25 historical shares outstanding datapoints in our CUE shares outstanding history coverage, used to compute CUE market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CUE market cap history over the course of time is important for investors interested in comparing CUE's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CUE versus a peer is one thing; comparing CUE market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CUE can fluctuate over the course of history. With this page we aim to empower investors researching CUE by allowing them to research the CUE market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree CUE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Cue Biopharma (CUE) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

CUR Market Cap History
CUTR Market Cap History
CVKD Market Cap History
CVRX Market Cap History
CVS Market Cap History
CWBR Market Cap History
CYCC Market Cap History
CYCN Market Cap History
CYH Market Cap History
CYRX Market Cap History
More Healthcare companies »

 

CUE Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.